Every year, on December 1, the world commemorates World AIDS Day. People around the world unite to show support for people living with and affected by HIV and to remember those who lost their lives to AIDS. ()
Here are some experts from Ï㽶ÊÓƵ who can comment on this topic:
, Full Professor, Department of Medicine, Division of Experimental Medicine
Dr. Catherine Hankins, Professor at the Department of Epidemiology, Biostatistics and Occupational Health and co-chair of Canada's COVID-19 Immunity Task Force is quoted by the Globe and Mail.
"…Dr. Catherine Hankins, a professor of public and population health at Ï㽶ÊÓƵ in Montreal, distinctly remembers reading the now-iconic MMWR report 40 years ago. "It was one of those 'where were you when…' moments," she said.
Across the country, the week of November 21 to December 1 marks Canadian HIV/AIDS Awareness Week. It’s an occasion to raise awareness surrounding HIV/AIDS issues nationally and culminates in the international observance of World AIDS Day on December 1st of each year – a day dedicated to increasing awareness of HIV/AIDS issues worldwide. ()
Here is an expert from Ï㽶ÊÓƵ that can provide comment on this issue:
Reducing stigma may address cognitive impairment in this population
A new study has drawn a direct link between the amount of stigma men with HIV report experiencing and their scores on cognitive tests, measuring abilities such as memory and attention.
"The International AIDS Conference is the largest conference on any global health issue in the world. First convened during the peak of the AIDS epidemic in 1985, it continues to provide a unique forum for the intersection of science, advocacy, and human rights. Each conference is an opportunity to strengthen policies and programmes that ensure an evidence-based response to the epidemic. The 22nd International AIDS Conference (AIDS 2018) will be hosted in Amsterdam, Netherlands 23-27 July 2018." ()
By Neuro Staff
When the general public thinks of HIV, they do not think of a neurological disease, yet people living with HIV infection know they need to worry about their brain health.
Untreated, HIV can cause severe dementia. Even with good control of the infection, a third or more of patients have problems with thinking or concentration, and many have mental health challenges. These issues are of particular concern in those over 50, a rapidly expanding group given the success of modern antiretroviral treatment.
Study tracks patients to better understand effects and possible treatments
December 1 is World AIDS Day, a time to raise awareness about a disease that has afflicted 70 million people worldwide, 35 million of whom have died as a result.
December 1 is World AIDS Day, reminding us that the fight against the AIDS pandemic is far from over. More than 36 million people have died since it emerged in the early 1980s. Today, 35.3 million people around the world are living with the virus. 73,000 Canadians are currently HIV positive up from 49,000 in 2001, according to statistics from the Canadian Foundation for AIDS Research (CanFAR).
A Canadian research team at the IRCM in Montréal, led by molecular virologist Éric A. Cohen, PhD, made a significant discovery on how HIV escapes the body’s antiviral responses. The team uncovered how an HIV viral protein known as Vpu tricks the immune system by using its own regulatory process to evade the host’s first line of defence. This breakthrough was published yesterday in the scientific journal PLoS Pathogens and will be presented at the upcoming IAS 2015 conference in Vancouver. The findings pave the way for future HIV prevention or cure strategies.
November 27, 2012 - Clinician-scientists take a unique, integrated approach that is essential to advancing science and medicine. Problems encountered in the clinic inspire research and new findings from the labs are directly applied to patients’ needs. The integrated model is a hallmark of the Montreal Neurological Institute and Hospital – The Neuro, at Ï㽶ÊÓƵ and the MUHC and is now being replicated worldwide. Two clinician-scientists at The Neuro have been awarded grants today to further research on Parkinson’s disease and HIV/AIDS.
